Silver Book Fact

Healthcare costs of atrial fibrillation

Atrial fibrillation (AF) is a major economic burden for society with the biggest cost driver being hospitalizations—accounting for 52% of costs. Drugs for AF account for 23% of costs, consultations at 9%, further investigations at 8%, loss of work at 6%, and paramedical procedures at 2%.

Le Heuzey, J-Y, O Paziaud, O Piot, SM Ait, X Copie, T Lavergne, and L Guize. Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study. Am Heart J. 2004; 147(1): 121-6. http://www.ahjonline.com/article/S0002-8703%2803%2900524-6/abstract

Reference

Title
Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study
Publication
Am Heart J
Publication Date
2004
Authors
Le Heuzey, J-Y, O Paziaud, O Piot, SM Ait, X Copie, T Lavergne, and L Guize
Volume & Issue
Volume 147, Issue 1
Pages
121-6
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • AFib prevalence projected to double by 2050
    By 2050, the prevalence of atrial fibrillation will have more than doubled since 2001—growing to an estimated 5.6 million to 12.1 million Americans.  
  • Annual AFib care
    Each year AFib leads to around 350,000 hospitalizations, 5 million office visits, 276,000 emergency department visits, and 234,000 hospital outpatient department visits.  
  • Atrial fibrillation prevalence, 2007
    An estimated 2.2 million Americans have atrial fibrillation and most are over the age of 65.  
  • Hospital readmission rates among AFib patients
    In the year following initial hospitalization for atrial fibrillation (AF), 12.5% of chronic AF patients were readmitted for AF—17.6% of readmissions occurred within 1 month. Among newly-diagnosed patients, 10.1% were…  
  • Median age AFib patient
    The median age of people with atrial fibrillation is about 75 years.